- call +1-201-465-4211
- email sales@mrinsights.biz
Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.
Scope of the Report:
This report studies the Tardive Dyskinesia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tardive Dyskinesia market by product type and applications/end industries.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
The global Tardive Dyskinesia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tardive Dyskinesia.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Valeant Pharmaceuticals
Neurocrine Biosciences
Teva Pharmaceuticals Industries
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Dopamine-Depleting Medications
GABA Receptor Agonist Medications
Anticholinergic Medications
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Tardive Dyskinesia Market Overview
1.1 Product Overview and Scope of Tardive Dyskinesia
1.2 Classification of Tardive Dyskinesia by Types
1.2.1 Global Tardive Dyskinesia Revenue Comparison by Types (2017-2023)
1.2.2 Global Tardive Dyskinesia Revenue Market Share by Types in 2017
1.2.3 Dopamine-Depleting Medications
1.2.4 GABA Receptor Agonist Medications
1.2.5 Anticholinergic Medications
1.3 Global Tardive Dyskinesia Market by Application
1.3.1 Global Tardive Dyskinesia Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Tardive Dyskinesia Market by Regions
1.4.1 Global Tardive Dyskinesia Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Tardive Dyskinesia Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tardive Dyskinesia Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tardive Dyskinesia Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Tardive Dyskinesia Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tardive Dyskinesia Status and Prospect (2013-2023)
1.5 Global Market Size of Tardive Dyskinesia (2013-2023)
2 Manufacturers Profiles
2.1 Valeant Pharmaceuticals
2.1.1 Business Overview
2.1.2 Tardive Dyskinesia Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Valeant Pharmaceuticals Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.2 Neurocrine Biosciences
2.2.1 Business Overview
2.2.2 Tardive Dyskinesia Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Neurocrine Biosciences Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceuticals Industries
2.3.1 Business Overview
2.3.2 Tardive Dyskinesia Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)
3 Global Tardive Dyskinesia Market Competition, by Players
3.1 Global Tardive Dyskinesia Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Tardive Dyskinesia Players Market Share
3.2.2 Top 10 Tardive Dyskinesia Players Market Share
3.3 Market Competition Trend
4 Global Tardive Dyskinesia Market Size by Regions
4.1 Global Tardive Dyskinesia Revenue and Market Share by Regions
4.2 North America Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
4.3 Europe Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
4.5 South America Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
5 North America Tardive Dyskinesia Revenue by Countries
5.1 North America Tardive Dyskinesia Revenue by Countries (2013-2018)
5.2 USA Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
5.3 Canada Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
5.4 Mexico Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
6 Europe Tardive Dyskinesia Revenue by Countries
6.1 Europe Tardive Dyskinesia Revenue by Countries (2013-2018)
6.2 Germany Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
6.3 UK Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
6.4 France Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
6.5 Russia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
6.6 Italy Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Tardive Dyskinesia Revenue by Countries
7.1 Asia-Pacific Tardive Dyskinesia Revenue by Countries (2013-2018)
7.2 China Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
7.3 Japan Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
7.4 Korea Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
7.5 India Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
8 South America Tardive Dyskinesia Revenue by Countries
8.1 South America Tardive Dyskinesia Revenue by Countries (2013-2018)
8.2 Brazil Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
8.3 Argentina Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
8.4 Colombia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Tardive Dyskinesia by Countries
9.1 Middle East and Africa Tardive Dyskinesia Revenue by Countries (2013-2018)
9.2 Saudi Arabia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
9.3 UAE Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
9.4 Egypt Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
9.5 Nigeria Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
9.6 South Africa Tardive Dyskinesia Revenue and Growth Rate (2013-2018)
10 Global Tardive Dyskinesia Market Segment by Type
10.1 Global Tardive Dyskinesia Revenue and Market Share by Type (2013-2018)
10.2 Global Tardive Dyskinesia Market Forecast by Type (2018-2023)
10.3 Dopamine-Depleting Medications Revenue Growth Rate (2013-2023)
10.4 GABA Receptor Agonist Medications Revenue Growth Rate (2013-2023)
10.5 Anticholinergic Medications Revenue Growth Rate (2013-2023)
11 Global Tardive Dyskinesia Market Segment by Application
11.1 Global Tardive Dyskinesia Revenue Market Share by Application (2013-2018)
11.2 Tardive Dyskinesia Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Tardive Dyskinesia Market Size Forecast (2018-2023)
12.1 Global Tardive Dyskinesia Market Size Forecast (2018-2023)
12.2 Global Tardive Dyskinesia Market Forecast by Regions (2018-2023)
12.3 North America Tardive Dyskinesia Revenue Market Forecast (2018-2023)
12.4 Europe Tardive Dyskinesia Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Tardive Dyskinesia Revenue Market Forecast (2018-2023)
12.6 South America Tardive Dyskinesia Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Tardive Dyskinesia Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Tardive Dyskinesia Picture
Table Product Specifications of Tardive Dyskinesia
Table Global Tardive Dyskinesia and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
